PFIZER INC
8-K, EX-99, 2000-08-16
PHARMACEUTICAL PREPARATIONS
Previous: PFIZER INC, 8-K, 2000-08-16
Next: PHELPS DODGE CORP, S-3, 2000-08-16

EXHIBIT 99

PFIZER INC. AND SUBSIDIARY COMPANIES
CONDENSED CONSOLIDATED STATEMENT OF INCOME
(UNAUDITED)

(millions of dollars, except per share data)

One Month 
     2000 

Seven Months 
        2000 

     

Revenues

$2,250 

$16,513 

Costs and expenses:

   

Cost of sales

363 

2,725 

Selling, informational and administrative expenses

811 

6,481 

Research and development expenses

318 

2,464 

Merger-related costs

218 

2,487 

Other income-net

   (10)

   (271)

     

Income before provision for taxes on income and minority interests

550 

2,627 

Provision for taxes on income

151 

1,278 

Minority interests

     1 

      6 

Net income

$  398 
====== 

$ 1,343 
======= 

     

Basic earnings per common share

$  .07 
====== 

$   .22 
======= 

     

Diluted earnings per common share

$  .06 
====== 

$   .21 
======= 

 

  1. The above financial statements present the periods ended July 30, 2000. Certain subsidiaries operating outside the United States are included on the basis of a one month lag.
  2. The financial results for the periods ended July 30, 2000 are not necessarily indicative of the results which ultimately might be achieved for the current year.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission